Brad Wood MD

Brad Wood, M.D.

  • Center for Cancer Research
  • National Cancer Institute
  • Building 10, Room 1C341
  • Bethesda, MD 20892
  • 301-443-8191
Urologic Oncology Branch


Dr. Bradford Wood directs a multi-disciplinary team at the NIH Center for Interventional Oncology that develops and translates devices, software and navigation approaches for cancer patients via novel local and regional minimally-invasive image-guided therapies.

At CCR, Dr. Wood serves as an adjunct investigator in the Urologic Oncology Branch's clinical core and is also a member of the NCI CCR Liver Cancer Program.

Areas of Expertise

Navigation tools for local and regional tumor ablation and embolization
Local drug delivery with micro- and nano-carriers
Fusion interventions, medical-GPS, or multi-modality, image-guided procedures
Immuno-modulation with local and regional therapies in interventional oncology

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.


Selected Recent Publications

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer

Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA
JAMA. 313(4): 390-397, 2015. [ Journal Article ]

First Human Experience with Directly Image-able Iodinated Embolization Microbeads

Levy EB, Krishnasamy VP, Lewis AL, Willis S, Macfarlane C, Anderson V, van der Bom IM, Radaelli A, Dreher MR, Sharma KV, Negussie A, Mikhail AS, Geschwind JF, Wood BJ
Cardiovasc Intervent Radiol. 39(8): 1177-86, 2016. [ Journal Article ]

Combined locoregional-immunotherapy for liver cancer

Greten TF, Mauda-Havakuk M, Heinrich B, Korangy F, Wood BJ.
J Hepatol. 70(5): 999-1007, 2019. [ Journal Article ]

In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer

Negussie AH, Mikhail AS, Owen JW, Hong N, Carlson CJ, Tang Y, Carrow KP, Mauda-Havakuk M, Lewis AL, Karanian JW, Pritchard WF, Wood BJ
Scientific Reports. 12(1): 21886, 2022. [ Journal Article ]

Artificial Intelligence for the detection of COVID-19 Pneumonia on Chest CT using Multinational Datasets

Harmon SA, Sanford TH, Xu S, Turkbey EB, Roth H, Xu Z,Yang D, Myronenko A, Anderson V, Amalou A, Blain M, Kassin M, Long D, Varble N, Walker SM, Bagci U , Ierardi AM, Stellato E, Plenisich GG, Franceschelli G, Girlando C, Irmici G, Labella D, Hammoud D, Malayeri A, Jones E, Summers RM, Choyke PL, Xu D, Flores M, Tamura K, Obinata H, Mori H, Patella F, Cariati M, Carrafiello G, An P*, Wood BJ*, Turkbey B*
Nature Comm. 11(1): 4080, 2020.
Full-Text Article
[ Journal Article ]


Senior Scientist
Sheng Xu, Ph.D.
Staff Scientist Physiologist
John Karanian, Ph.D.
Bill Pritchard, M.D. Ph.D.
Medical Officer
William Pritchard, M.D. Ph.D.
Andrew Mikhail, PhD
Staff Scientist
Andrew Mikhail, Ph.D.
Mike Kassin, MD
Interventional Radiologist (NIH Clinical Center)
Michael Kassin, M.D.
Ayele Negussie, Ph.D.
Program Coordinator
Lindsey Hazen, R.N.
Research Nurse (Regulatory)
Charisse Garcia, R.N.
Research Nurse
Merideth Digenarro, R.N.


NIH Clinical trials using commercialized NIH fusion biopsy inventions are reported in JAMA and New England Journal of Medicine demonstrating improved prostate cancer diagnosis, characterization and triage.